Breakthrough T1D
Concentration RiskAbout
Breakthrough T1D (formerly JDRF Australia) is the international leader in type 1 diabetes research, working to create a future without T1D while improving lives today. The organisation supports 145,000+ Australians living with type 1 diabetes by funding cutting-edge research, clinical trials, advocacy, and community support programs. They invest in research projects across Australia aimed at finding cures, developing disease-modifying therapies, and improving everyday life for those with T1D.
Giving Philosophy
Breakthrough T1D funds the brightest researchers in Australia and internationally to find cures for T1D and improve treatments. They prioritize evidence-based research projects with potential for clinical impact, supporting clinical trials, disease-modifying therapies, and screening programs. Their approach is strategic, focusing on projects that bring measurable progress toward cures and better care.
Tips for Applicants
Researchers should demonstrate clear potential for clinical impact and align with Breakthrough T1D's strategic priorities, particularly disease-modifying therapies and screening programs. Building relationships through their Clinical Research Network and attending their events can help establish connections with the organisation.
Programs & Opportunities (1)
Breakthrough T1D offers conference support grants to facilitate collaboration and information sharing within the local type 1 diabetes research community, available to Australian-based organisations.
Financial History (7 years)
| Year | Revenue | Expenses | Assets | Surplus |
|---|---|---|---|---|
| 2023 | $19.2M | $18.5M | $24.4M | $715K |
| 2022 | $22.6M | $21.4M | $21.1M | $1.4M |
| 2021 | $19.8M | $17.8M | $22.5M | $2.0M |
| 2020 | $19.7M | $19.0M | $18.9M | $740K |
| 2019 | $18.2M | $23.1M | $18.9M | $-423,622 |
| 2018 | $18.4M | $17.5M | $28.2M | $949K |
| 2017 | $17.6M | $16.4M | $25.3M | $1.2M |
Community Evidence
External EvidenceIdentity
- GS ID
- AU-ABN-40002286553
- ABN
- 40002286553
- Sector
- health
- Website
- breakthrought1d.org.au/
- Financial Year
- 2023
Focus Areas
Financials
- Revenue
- $19.2M
- Assets
- $24.4M
Method
- Match Confidence
- registry
- Cross-references
- 2 datasets
- Match Key
- ABN
- Relationships
- 22
Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.
Data Sources
Location Intelligence
- Postcode
- 2065
- Locality
- Crows Nest - Waverton
- Remoteness
- Major Cities of Australia
- SEIFA Disadvantage
- Decile 10/10
- LGA
- Willoughby
- SA2 Region
- Crows Nest - Waverton
- Entities in Area
- 762